A fresh wave of layoffs jolted the Bay Area during March with several rounds of cutbacks that erased well over 600 jobs.

Story March 27 - Nkarta: The South San Francisco-based company is laying off 34% of its workforce—representing 53 employees—including half of the biotech’s executive leadership, as the ...

Sutro Biopharma, a South San Francisco company working to design anti-cancer drugs, is a fresh face for biotech’s extreme risk — and its fallout. As of this year, the company had racked up ...

Late last year, the chief leasing officer for Kilroy Realty Corp. saw more biotech companies showing interest in the second ...

A Bay Area biotech company is laying off approximately 90 percent of its workforce. According to a press release, Cargo Therapeutics announced the layoffs on Tuesday. The move was ...

The San Francisco-based company said it had profit of 18 cents per share. Losses, adjusted to account for discontinued operations, came to 8 cents per share. The biotech drug developer posted revenue ...

A bankruptcy filing Sunday by 23andMe, a genetic testing and biotechnology company, is shining light on what could happen to ...